Notes / Company

Panjon Ltd.

PANJON BSE 526345 ISIN INE744D01019 Pharmaceuticals

Fundamentals

Market cap: ₹30.45 cr
P/E: 50.83×
ROE: 2.47%
Debt / equity: 0.16
52-week range: 16.10 — 30.00

Research on Tijori Finance

Company snapshot

Panjon Ltd.

Pharmaceuticals

₹31 cr

P/E 51.55×

Latest quarter · Mar 2026

Sales₹12 cr

Net profit₹0 cr

Op. margin+2.0%

EPS₹0.04

Strength & growth

Debt / equity0.16×

Current ratio3.69×

Sales CAGR+15.1%

The timeline — 2 notes on Panjon Ltd.

June 2026

20 Jun 26 · 2:37 PM IST Brief

Brief · Earnings · Micro cap

Panjon's FY26 results get clean audit, but no surprises

Audited numbers confirm 56% revenue jump to ₹47.62 cr, but net profit remains thin at ₹0.60 cr. All key figures were already disclosed.

May 2026

29 May 26 · 8:37 PM IST Brief

Brief · Earnings · Micro cap

Panjon's full-year revenue surges 56%, but the last quarter contracts

Annual revenue hit ₹47.92 crore, but Q4 total income fell to ₹12.29 crore from ₹13.88 crore a year ago. Net profit for the year was ₹72.45 lakhs.

Verify on exchange BSE filings for PANJON NSE filings for PANJON Tijori Finance company page